Neuroblastoma conference comes Down Under for the first time
26 May, 2016The Advances in Neuroblastoma Research Congress is coming to the Cairns Convention Centre next month, marking the first time the biennial conference has been held in the Southern Hemisphere.
Nominations open for 36th Award for Research Excellence
24 May, 2016GSK has opened up nominations for its annual Award for Research Excellence (ARE), said to be one of the most prestigious available to the Australian medical research community.
Why does gestational diabetes lead to type 2 diabetes?
19 May, 2016For decades, scientists have been baffled as to why gestational diabetes often leads to type 2 diabetes. The answer could be in our genes' ability to change their behaviour due to signals from the environment.
Breath markers for malaria
11 May, 2016A CSIRO research team will spend the next 18 months field-testing its newly developed breath markers for malaria in locations such as Malawi, Bangladesh, Malaysia and Sudan.
Antibody slows the spread of cancers
29 April, 2016Scientists have discovered how to slow common cancers from metastasising, or spreading. It all comes down to three factors: immune cells known as natural killer (NK) cells, the protein CD96 and a monoclonal antibody.
A vaccination for heart attacks?
27 April, 2016The Australian Study for the Prevention through Immunisation of Cardiovascular Events is testing whether a safe, one-off vaccination can help to reduce the risk of heart attacks and strokes.
How diabetes disrupts the immune system
21 April, 2016Western Australian scientists have led new research into how type 1 diabetes disrupts the body's immune system — a finding that could help focus the search for a cure for the condition.
A protein to reverse cognitive decline
19 April, 2016Scientists have discovered that a protein called IL-33 can reverse Alzheimer's disease-like pathology and cognitive decline in mice, giving hope to the 65 million people who are projected to develop the disease by 2030.
Innate exceeds SPMS trial recruitment target
13 April, 2016Innate Immunotherapeutics has closed enrolment in its Phase 2B efficacy trial of MIS416 in patients with secondary progressive multiple sclerosis, having this week exceeded the original recruitment target of 90 subjects.
Grand Challenges Explorations Round 17 open
06 April, 2016The Bill & Melinda Gates Foundation is currently accepting applications for the 17th round of Grand Challenges Explorations, an initiative to encourage innovative and unconventional global health and development solutions.
What's your risk of breaking a bone?
06 April, 2016Researchers from the University of Southampton have led a study into the risks of an individual experiencing a fracture in their lifetime.
Malaria from the age of the dinosaurs?
04 April, 2016A researcher from Oregon State University has claimed that malaria evolved in insects at least 100 million years ago. His research suggests that the first vertebrate hosts of this disease were probably reptiles, which at that time would have included the dinosaurs.
MoU to strengthen biomedical science partnership
31 March, 2016The Australian Institute of Medical Scientists and the UK Institute of Biomedical Science have signed a memorandum of understanding that is intended to strengthen the partnership between the two organisations.
Antibody assets to be developed for cancer treatment
29 March, 2016Shares in Patrys rose almost 30% as the company announced that it will develop and commercialise as anticancer agents a portfolio of preclinical novel anti-DNA antibodies and antibody fragments/variants discovered at Yale University.
Phase IIb Parkinson's trial approved
24 March, 2016Living Cell Technologies has received approval from the Auckland Hospital Research Review Committee for its Phase IIb clinical trial of NTCELL for Parkinson's disease.
